🔎 Trials Near Me

Home › Multiple Myeloma › Florida › Jacksonville

Multiple Myeloma clinical trials in Jacksonville, FL

18 studies for Multiple Myeloma are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • Mayo Clinic Jacksonville, Jacksonville
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07258511

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 3
  • Mayo Clinic Jacksonville, Jacksonville
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07518186

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

RecruitingPhase 1
  • Mayo Clinic in Florida, Jacksonville
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06465316

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

RecruitingPhase 3
  • Baptist MD Anderson Cancer Center, Jacksonville
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 2
  • Mayo Clinic in Florida, Jacksonville
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06297226

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

RecruitingPhase 1
  • Mayo Clinic Florida, Jacksonville
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT06375044

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

RecruitingPhase 1
  • Mayo Clinic Hospital - Florida, Jacksonville
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

RecruitingPhase 1/2
  • Research Site, Jacksonville
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05850234

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Recruiting
  • Mayo Clinic in Florida, Jacksonville
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06630104

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

RecruitingPhase 2
  • Mayo Clinic - Florida, Jacksonville
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07284758

Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

RecruitingPhase 2
  • Mayo Clinic in Florida, Jacksonville
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05847569

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

RecruitingPhase 3
  • Mayo Clinic in Florida, Jacksonville
All ages · All sexes · Updated Jun 10, 2026 · NCT05561387

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

RecruitingPhase 2
  • Mayo Clinic in Florida, Jacksonville
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT05969860

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

RecruitingPhase 1
  • Cancer Specialists, LLC, Jacksonville
Ages 18 and older · All sexes · Updated Nov 1, 2023 · NCT03110822

About Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.

More about Multiple Myeloma on MedlinePlus

Multiple Myeloma trials in other cities

Other studies in Jacksonville

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.